Multicenter Randomized Controlled Study of Adipose Mesenchymal Stem Cells (ADSCs) Rich Nanofat Injection for treatment of Temporomandibular Joint Disease (TMD)

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: Sodium hyaluronate injection into the supra‐articular space:Articular cavity injection HA;Supra‐articular chamber injection of ADSCs nanofat:Articular cavity fat injection; CONDITION: Temporomandibular Disorders PRIMARY OUTCOME: Opening degree;MRI Imaging;Pain relief situation; INCLUSION CRITERIA: Patients diagnosed with TMD according to the diagnostic criteria of RDC/TMD with the following criteria: having impaired motion or pain in the mandibular joint with a VAS value of >4; having a history of significant painful elastic murmur in the joint area; having a history of pain with joint disc displacement and pain without joint disc displacement; the patient is in good general condition without systemic diseases such as rheumatism; being able to cooperate with the examination and taking a complete medical history; MRI showing normal or abnormal joint disc position and structure.
Epistemonikos ID: 0046436dea3ea5c4b0e6b29d0235ecbf41a63008
First added on: Feb 20, 2024